Khan MA - Search Results

1

p53 mutations in cyclophosphamide-associated bladder cancer.

Khan MA, Travis LB, Lynch CF, Soini Y, Hruszkewycz AM, Delgado RM, Holowaty EJ, van Leeuwen FE, Glimelius B, Stovall M, Boice JD Jr, Tarone RE, Bennett WP. Khan MA, et al. Cancer Epidemiol Biomarkers Prev. 1998 May;7(5):397-403. Cancer Epidemiol Biomarkers Prev. 1998. PMID: 9610789

2

EGFR somatic mutations in lung tumors: radon exposure and passive smoking in former- and never-smoking U.S. women.

Taga M, Mechanic LE, Hagiwara N, Vähäkangas KH, Bennett WP, Alavanja MC, Welsh JA, Khan MA, Lee A, Diasio R, Edell E, Bungum A, Jang JS, Yang P, Jen J, Harris CC. Taga M, et al. Among authors: khan ma. Cancer Epidemiol Biomarkers Prev. 2012 Jun;21(6):988-92. doi: 10.1158/1055-9965.EPI-12-0166. Epub 2012 Apr 20. Cancer Epidemiol Biomarkers Prev. 2012. PMID: 22523180 Free PMC article.

3

p53 mutation spectrum in relation to GSTM1, CYP1A1 and CYP2E1 in surgically treated patients with non-small cell lung cancer.

Przygodzki RM, Bennett WP, Guinee DG Jr, Khan MA, Freedman A, Shields PG, Travis WD, Jett JR, Tazelaar H, Pairolero P, Trastek V, Liotta LA, Harris CC, Caporaso NE. Przygodzki RM, et al. Among authors: khan ma. Pharmacogenetics. 1998 Dec;8(6):503-11. doi: 10.1097/00008571-199812000-00007. Pharmacogenetics. 1998. PMID: 9918134

4

p53 and K-ras mutations in lung cancers from former and never-smoking women.

Vähäkangas KH, Bennett WP, Castrén K, Welsh JA, Khan MA, Blömeke B, Alavanja MC, Harris CC. Vähäkangas KH, et al. Among authors: khan ma. Cancer Res. 2001 Jun 1;61(11):4350-6. Cancer Res. 2001. PMID: 11389059

5

FHIT mutations in human primary gastric cancer.

Gemma A, Hagiwara K, Ke Y, Burke LM, Khan MA, Nagashima M, Bennett WP, Harris CC. Gemma A, et al. Among authors: khan ma. Cancer Res. 1997 Apr 15;57(8):1435-7. Cancer Res. 1997. PMID: 9108441

6

Differential effects of p53 mutants on the growth of human bronchial epithelial cells.

Coursen JD, Bennett WP, Khan MA, Forrester K, Pietenpol JA, Harris CC. Coursen JD, et al. Among authors: khan ma. Mol Carcinog. 1997 Jul;19(3):191-203. Mol Carcinog. 1997. PMID: 9254886

7

Allelic deletion analysis of the FHIT gene predicts poor survival in non-small cell lung cancer.

Burke L, Khan MA, Freedman AN, Gemma A, Rusin M, Guinee DG, Bennett WP, Caporaso NE, Fleming MV, Travis WD, Colby TV, Trastek V, Pairolero PC, Tazelaar HD, Midthun DE, Liotta LA, Harris CC. Burke L, et al. Among authors: khan ma. Cancer Res. 1998 Jun 15;58(12):2533-6. Cancer Res. 1998. PMID: 9635574

8

Vascular endothelial growth factor and nitric oxide synthase expression in human lung cancer and the relation to p53.

Ambs S, Bennett WP, Merriam WG, Ogunfusika MO, Oser SM, Khan MA, Jones RT, Harris CC. Ambs S, et al. Among authors: khan ma. Br J Cancer. 1998 Jul;78(2):233-9. doi: 10.1038/bjc.1998.470. Br J Cancer. 1998. PMID: 9683299 Free PMC article.

9

Molecular epidemiology of human cancer risk: gene-environment interactions and p53 mutation spectrum in human lung cancer.

Bennett WP, Hussain SP, Vahakangas KH, Khan MA, Shields PG, Harris CC. Bennett WP, et al. Among authors: khan ma. J Pathol. 1999 Jan;187(1):8-18. doi: 10.1002/(SICI)1096-9896(199901)187:1<8::AID-PATH232>3.0.CO;2-Y. J Pathol. 1999. PMID: 10341702 Review.

10

Semiautomated sequence-specific mutation detection of the human K-ras oncogene using "cold" SSCP analysis.

Hruszkewycz AM, Delgado RM, Khan MA, Bennett WP. Hruszkewycz AM, et al. Among authors: khan ma. Clin Chem. 1996 Oct;42(10):1717-9. Clin Chem. 1996. PMID: 8855163 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,148 results

Search Page